Stocks
Bluebird Bio (BLUE) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 170.7% | 11.6% | 628.2% | 367.2% | 30.7% | 13.8% | |||
| Changes by years, y/y, % | +69pp | -159pp | +617pp | -261pp | -336pp | -21.4% | |||
Bluebird Bio. CAPEX/Revenue, %
Bluebird Bio. CAPEX/Revenue, changes, pp
Bluebird Bio (BLUE) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2024Q1 | 2023Q4 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 16.4% | 9.56% | 66.6% | 0.37% | 2.64% | 13.8% | ||
| Changes by years, y/y, % | -1 764pp | -37pp | -8 172pp | -10pp | -14pp | |||
| Changes by quarters, q/q, % | +6pp | -7pp | +57pp | -66pp | +2pp | |||
